Spruce Biosciences' GAAP loss for 2021 was $42.292 million, up 43.2% from $29.539 million the previous year.
Spruce Biosciences' GAAP loss for 2021 was $42.292 million, up 43.2% from $29.539 million the previous year.
Spruce Biosciences reports for 2021
Spruce Biosciences' GAAP loss for 2021 was $42.292 million, up 43.2% from $29.539 million the previous year. Source: 
investors.sprucebiosciences.com
investors.sprucebiosciences.com
English (US) 